These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19133165)

  • 41. Endovascular management of cerebral vasospasm.
    McGuinness B; Gandhi D
    Neurosurg Clin N Am; 2010 Apr; 21(2):281-90. PubMed ID: 20380970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of delayed cerebral ischemia after subarachnoid hemorrhage.
    Koenig MA
    Continuum (Minneap Minn); 2012 Jun; 18(3):579-97. PubMed ID: 22810250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.
    Dabus G; Nogueira RG
    Interv Neurol; 2013 Oct; 2(1):30-51. PubMed ID: 25187783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study.
    Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K
    Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anesthetic considerations of selective intra-arterial nicardipine injection for intracranial vasospasm: a case series.
    Avitsian R; Fiorella D; Soliman MM; Mascha E
    J Neurosurg Anesthesiol; 2007 Apr; 19(2):125-9. PubMed ID: 17413999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage.
    Kerz T; Boor S; Beyer C; Welschehold S; Schuessler A; Oertel J
    Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?
    Capampangan DJ; Wellik KE; Aguilar MI; Demaerschalk BM; Wingerchuk DM
    Neurologist; 2008 Nov; 14(6):395-8. PubMed ID: 19008746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnesium therapy within 48 hours of an aneurysmal subarachnoid hemorrhage: neuro-panacea.
    Wong GK; Chan MT; Poon WS; Boet R; Gin T
    Neurol Res; 2006 Jun; 28(4):431-5. PubMed ID: 16759446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does treatment modality affect vasospasm distribution in aneurysmal subarachnoid hemorrhage: differential use of intra-arterial interventions for cerebral vasospasm in surgical clipping and endovascular coiling populations.
    Cooke D; Seiler D; Hallam D; Kim L; Jarvik JG; Sekhar L; Ghodke B
    J Neurointerv Surg; 2010 Jun; 2(2):139-44. PubMed ID: 21990594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies.
    Hasegawa S; Hasegawa Y; Miura M
    Curr Drug Deliv; 2017 Sep; 14(6):843-852. PubMed ID: 27501717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical management of cerebral vasospasm: present and future.
    Zubkov AY; Rabinstein AA
    Neurol Res; 2009 Jul; 31(6):626-31. PubMed ID: 19055879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence-based cerebral vasospasm management.
    Weyer GW; Nolan CP; Macdonald RL
    Neurosurg Focus; 2006 Sep; 21(3):E8. PubMed ID: 17029347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage.
    Sen J; Belli A; Albon H; Morgan L; Petzold A; Kitchen N
    Lancet Neurol; 2003 Oct; 2(10):614-21. PubMed ID: 14505583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral vasospasm after subarachnoid hemorrhage: an update.
    Kosty T
    Crit Care Nurs Q; 2005; 28(2):122-34. PubMed ID: 15875443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention and treatment of vasospasm.
    Levati A; Solaini C; Boselli L
    J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):27-31. PubMed ID: 9800599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endovascular management of cerebral vasospasm.
    Kelman C; Reavey-Cantwell J
    Neurosurg Focus; 2014 Jul; 37(1 Suppl):1. PubMed ID: 24983730
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endovascular Treatment of Symptomatic Vasospasm after Aneurysmal Subarachnoid Hemorrhage: A Three-year Experience.
    Park ES; Kim DW; Kang SD
    J Cerebrovasc Endovasc Neurosurg; 2017 Sep; 19(3):155-161. PubMed ID: 29159148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
    Kiser TH
    Hosp Pharm; 2013 Sep; 48(5 Suppl):S2-S9. PubMed ID: 35694374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?
    Kiser TH
    Hosp Pharm; 2014 Nov; 49(10):923-41. PubMed ID: 25477565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.